The proceeds will be mainly used to its R&D advancement.
Vascular interventional surgery robot
Carbon Med recently annouced its completion of the pre-Series A financing round valued at tens of millions of CNY.
This round was led by Jinding Capital and Shenzhen Zhongxiao. The funding will be used for the channel construction of its new medical products, R&D of new projects, clinilcal support and team building.
Founded in April 2018, Carbon Medical is specialized in the field of non-vascular interventional therapy. Leveraging its image fusion ultrasound platform technology, Carbon Medical provides a full set of equipment and surgical supplies for urology, hepatobiliary surgery, rehabilitation department and other surgical departments.
Computing power is productivity: An infrastructure competition concerning the next ten years
May 20, 2026 11:05 AM
From a "Huawei substitute" to falling out of the top five: Where exactly did Honor lose?
May 19, 2026 12:00 PM